Final dividend for the year ended 31 December 2023

EF001 Disclaimer Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arisen from or in reliance upon the whole or any part of the contents of this announcement.Cash Dividend Announcement for Equity Issuer Issuer name Shandong Xinhua Pharmaceutical Company Limited Stock code 00719 Multi-counter stock code and currency Not applicable Other related stock code(s) and Not applicable name(s) Title of announcement Final dividend for the year ended 31 December 2023 Announcement date 26 June 2024 Status Update to previous announcement Update the following items: the information relating to Hong Kong share register and the Reason for the update / change Information relating to withholding tax and to supplement the date of shareholders' approval relating to the dividend Information relating to the dividend Dividend type Final Dividend nature Ordinary For the financial year end 31 December 2023 Reporting period end for the dividend declared 31 December 2023 Dividend declared RMB 0.25 per share Date of shareholders' approval 26 June 2024 Information relating to Hong Kong share register Default currency and amount in which the dividend will be paid HKD 0.274098 per share Exchange rate RMB 1 : HKD 1.096393 Ex-dividend date 10 July 2024 Latest time to lodge transfer documents for registration with share registrar for 11 July 2024 16:30 determining entitlement to the dividend Book close period From 12 July 2024 to 18 July 2024 Record date 18 July 2024 Payment date 30 July 2024 Hong Kong Registrars Limited Shops 1712 – 1716 17th Floor Share registrar and its address Hopewell Centre 183 Queen’s Road East Wanchai Hong Kong Page 1 of 2 v 1.1.1EF001 Information relating to withholding tax WITHHELD AND PAYMENT OF THE INCOME TAX Type of shareholders Tax rate Other relevant information (if any) Enterprise - non-resident i.e. registered address 10% All Shareholders who will be outside PRC registered as overseas non- natural persons (i.e. non- individuals) on the Company's H share register of members including HKSCC Nominees Limited other nominees trustees or other groups and organizations are treated as overseas non-resident enterprise Shareholders and the Company shall distribute the 2023 Final Dividend to such overseas non- resident enterprise Shareholders Details of withholding tax applied to the after withholding the enterprise dividend declared income tax of 10% as required by law.Individual - resident i.e. registered address within 20% For dividends payable to PRC domestic individual investors and domestic securities investment funds from investing in H shares listed on the Stock Exchange of Hong Kong Limited through Shenzhen-Hong Kong Stock Connect and Shanghai-Hong Kong Stock Connect an H share issuer shall withhold individual income tax at the rate of 20% on behalf of such investors. An H- share issuer shall not withhold income tax on dividends for domestic corporate investors and those domestic corporate investors shall report and pay the relevant tax by themselves.Information relating to listed warrants / convertible securities issued by the issuer Details of listed warrants / convertible securities issued by the issuer Not applicable Other information Other information Not applicable Directors of the issuer As at the date of this announcement the Board comprises Mr. He Tongqing (Chairman) as an executive director; Mr. Xu Wenhui and Mr. Hou Ning as executive directors; Mr. Xu Lie and Mr. Zhang Chenyong as non-executive directors; and Mr. Pan Guangcheng Mr. Zhu Jianwei Mr. Ling Peixue and Ms. Cheung Ching Ching Daisy as independent non-executive directors.Page 2 of 2 v 1.1.1